U.S. Takes Equity in Helion and CFS for $260 Million in Fusion Awards
Helion and CFS secure $260 million in U.S. CHIPS awards for fusion chips, trading non-voting equity as federal backing reshapes private investment risk.
Summary
The U.S. Department of Commerce awarded Helion $175 million and Commonwealth Fusion Systems, or CFS, $85 million under the 2022 CHIPS and Science Act, funding advanced semiconductors that help power and control their fusion reactors. In exchange, both provide non-voting shares. Helion’s $175 million stake, priced from its $15.5 billion Series G valuation, is roughly 1%; CFS’s percentage is unknown because its latest valuation is private. CFS has raised about $4 billion, while Helion has $3.2 billion in committed capital. Helion’s David Kirtley says the structure aligns commercial success with taxpayers.
Private investors have put more than $14 billion into fusion, but the Fusion Industry Association sought a one-time $10 billion federal infusion in 2025, including $5.4 billion for startups, to implement the Department of Energy’s Fusion Roadmap and compete with China’s state-backed push. The Biden administration’s Milestone Based Fusion Development Program distributed less than $50 million in its first two years. The new awards signal renewed support, but come from Commerce rather than the requested research budget and add equity terms the trade group’s lobbying had not contemplated.
Federal financing already gave Washington 15% of MP Materials for $400 million plus a $150 million loan, purchase commitments and profit sharing; 10% of USA Rare Earth for a $277 million award and $1.3 billion loan; and roughly 10% of Intel after converting $8.9 billion in unpaid Biden awards. Proxima Fusion counts the German government, European Union, SPRIND and DCTF as investors, while Thea Energy, Avalanche Energy, Pacific Fusion and Inertia Enterprises say federal work involved no government stake; Inertia partners with Lawrence Livermore National Laboratory. The model could strengthen a U.S. strategic industry and let taxpayers share gains, but investors face dilution, unclear priority in financing or wind-downs, and a chilling effect as fusion seeks billions more.
Positives
- $260 million from the Commerce Department gives Helion and CFS substantially more federal support than earlier fusion programs provided.
- Helion’s roughly 1% government stake lets taxpayers participate if its $15.5 billion valuation grows through commercial success.
- More than $14 billion in private fusion investment now has stronger federal backing for strategically important reactor semiconductors.
- The 2022 CHIPS and Science Act awards support domestic technology needed to power and control advanced fusion reactors.
- Non-voting shares give the government financial exposure without direct voting authority over Helion or CFS.
Risks & concerns
- Helion and CFS must dilute existing shareholders, ending the traditional assumption that federal startup awards are non-dilutive.
- CFS has not disclosed its latest valuation, leaving the size of the government’s $85 million equity stake unknown.
- $260 million remains far below the Fusion Industry Association’s requested $10 billion infusion, including $5.4 billion for startups.
- Government ownership creates unresolved questions about priority during later financing rounds, distressed funding or company wind-downs.
- Federal equity requirements could discourage venture investment while fusion companies still need billions of dollars to reach commercial deployment.